Akebia Therapeutics Inc (AKBA)
1.155
+0.02
(+1.32%)
USD |
NASDAQ |
May 17, 16:00
1.155
0.00 (0.00%)
After-Hours: 20:00
Akebia Therapeutics Accounts Payable (Quarterly): 11.88M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 11.88M |
December 31, 2023 | 14.64M |
September 30, 2023 | 9.038M |
June 30, 2023 | 11.78M |
March 31, 2023 | 12.58M |
December 31, 2022 | 18.02M |
September 30, 2022 | 19.71M |
June 30, 2022 | 24.94M |
March 31, 2022 | 19.47M |
December 31, 2021 | 33.59M |
September 30, 2021 | 28.81M |
June 30, 2021 | 41.98M |
March 31, 2021 | 30.54M |
December 31, 2020 | 41.31M |
September 30, 2020 | 40.40M |
June 30, 2020 | 29.41M |
March 31, 2020 | 54.38M |
December 31, 2019 | 39.22M |
September 30, 2019 | 64.36M |
June 30, 2019 | 19.32M |
March 31, 2019 | 15.23M |
Date | Value |
---|---|
December 31, 2018 | 42.80M |
September 30, 2018 | 12.68M |
June 30, 2018 | 4.795M |
March 31, 2018 | 17.88M |
December 31, 2017 | 6.998M |
September 30, 2017 | 8.705M |
June 30, 2017 | 10.21M |
March 31, 2017 | 15.08M |
December 31, 2016 | 2.039M |
September 30, 2016 | 8.524M |
June 30, 2016 | 5.143M |
March 31, 2016 | 2.415M |
December 31, 2015 | 2.313M |
September 30, 2015 | 5.273M |
June 30, 2015 | 2.412M |
March 31, 2015 | 4.329M |
December 31, 2014 | 2.021M |
September 30, 2014 | 3.032M |
June 30, 2014 | 1.488M |
March 31, 2014 | 2.077M |
December 31, 2013 | 0.714M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
9.038M
Minimum
Sep 2023
64.36M
Maximum
Sep 2019
28.27M
Average
26.88M
Median
Accounts Payable (Quarterly) Benchmarks
Aquestive Therapeutics Inc | 10.52M |
Amicus Therapeutics Inc | 9.21M |
Insmed Inc | 44.02M |
Altimmune Inc | 3.76M |
InfuSystems Holdings Inc | 9.796M |